AAREYDRUGS
Invest Now
Start SIP in
AAREYDRUGS
Performance
- Low
- ₹68
- High
- ₹68
- 52 Week Low
- ₹31
- 52 Week High
- ₹75
- Open Price₹0
- Previous Close₹70
- Volume27,477
Investment Returns
- Over 1 Month + 23.34%
- Over 3 Month + 35.49%
- Over 6 Month + 29.84%
- Over 1 Year + 31.55%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48
- PEG Ratio
- -3.4
- Market Cap Cr
- 193
- P/B Ratio
- 1.5
- Average True Range
- 2.21
- EPS
- 1.42
- Dividend Yield
- 0
- MACD Signal
- 4
- RSI
- 60.16
- MFI
- 89.76
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹68.18
-1.4
(-2.01%)

-
- Bearish Moving Average 5
-
- Bullish Moving Average 11
- 20 Day
- ₹66.59
- 50 Day
- ₹60.60
- 100 Day
- ₹56.45
- 200 Day
- ₹54.38
Resistance and Support
68.22
- R3 68.38
- R2 68.34
- R1 68.26
- S1 68.14
- S2 68.10
- S3 68.02
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-30 | Audited Results | |
2025-02-14 | Quarterly Results | |
2024-12-04 | To consider Fund Raising | |
2024-11-29 | Preferential issue of shares | Inter alia: a) To consider a proposal for issuance of equity shares by way of a preferential allotment. |
2024-11-14 | Quarterly Results |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹68 As on 15 July, 2025 | 21:19
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹193.3 Cr As on 15 July, 2025 | 21:19
The P/E ratio of Aarey Drugs & Pharmaceuticals is 48 As on 15 July, 2025 | 21:19
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.5 As on 15 July, 2025 | 21:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.